US20230083446A1 - Method for Wound Infection Prevention - Google Patents
Method for Wound Infection Prevention Download PDFInfo
- Publication number
- US20230083446A1 US20230083446A1 US17/728,861 US202217728861A US2023083446A1 US 20230083446 A1 US20230083446 A1 US 20230083446A1 US 202217728861 A US202217728861 A US 202217728861A US 2023083446 A1 US2023083446 A1 US 2023083446A1
- Authority
- US
- United States
- Prior art keywords
- wound
- incision
- fluid
- strand
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 42
- 206010048038 Wound infection Diseases 0.000 title description 9
- 230000002265 prevention Effects 0.000 title description 6
- 206010052428 Wound Diseases 0.000 claims abstract description 99
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 91
- 239000012530 fluid Substances 0.000 claims abstract description 66
- 239000000463 material Substances 0.000 claims abstract description 42
- 208000015181 infectious disease Diseases 0.000 claims abstract description 26
- 230000029663 wound healing Effects 0.000 claims abstract description 21
- 238000004891 communication Methods 0.000 claims abstract description 8
- 239000002250 absorbent Substances 0.000 claims description 42
- 230000002745 absorbent Effects 0.000 claims description 42
- 239000011358 absorbing material Substances 0.000 claims description 12
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 206010033675 panniculitis Diseases 0.000 claims description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 claims description 2
- 238000007920 subcutaneous administration Methods 0.000 abstract description 18
- 239000010410 layer Substances 0.000 description 24
- 238000012856 packing Methods 0.000 description 12
- 238000001356 surgical procedure Methods 0.000 description 12
- 208000031650 Surgical Wound Infection Diseases 0.000 description 11
- 229920000742 Cotton Polymers 0.000 description 10
- 239000004677 Nylon Substances 0.000 description 9
- 229920001778 nylon Polymers 0.000 description 9
- 229920002994 synthetic fiber Polymers 0.000 description 8
- 239000004809 Teflon Substances 0.000 description 7
- 229920006362 Teflon® Polymers 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 230000035876 healing Effects 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 238000010276 construction Methods 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 210000003195 fascia Anatomy 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 210000003815 abdominal wall Anatomy 0.000 description 2
- 238000002682 general surgery Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- -1 but not limited to Polymers 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 238000007631 vascular surgery Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/05—Bandages or dressings; Absorbent pads specially adapted for use with sub-pressure or over-pressure therapy, wound drainage or wound irrigation, e.g. for use with negative-pressure wound therapy [NPWT]
-
- A61F13/00068—
-
- A61F13/00021—
-
- A61F13/00029—
-
- A61F13/00034—
-
- A61F13/00042—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01021—Non-adhesive bandages or dressings characterised by the structure of the dressing
- A61F13/01029—Non-adhesive bandages or dressings characterised by the structure of the dressing made of multiple layers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01034—Non-adhesive bandages or dressings characterised by a property
- A61F13/01042—Absorbency
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/02—Adhesive bandages or dressings
- A61F13/0203—Adhesive bandages or dressings with fluid retention members
- A61F13/0223—Adhesive bandages or dressings with fluid retention members characterized by parametric properties of the fluid retention layer, e.g. absorbency, wicking capacity, liquid distribution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/08—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound
- A61B17/085—Wound clamps or clips, i.e. not or only partly penetrating the tissue ; Devices for bringing together the edges of a wound with adhesive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00451—Plasters use for surgical sutures, e.g. butterfly type
- A61F2013/00455—Plasters use for surgical sutures, e.g. butterfly type for protection of suture stitches
Definitions
- the present invention relates generally to apparatus and methods for treating wounds, and more particularly, to an apparatus and method for healing closed incisions following surgery.
- Negative pressure treatments fail to effectively address the underlining cause of surgical site infection (SSI) in closed incisions.
- SSI surgical site infection
- VAC vacuum
- VAC systems are also very expensive and are physician and nurse-labor intensive.
- the data surrounding the VAC systems appears to be mixed and studies appear to show that these systems involve patients with fewer high risk factors prior to surgery.
- SSI infections may occur from the following, but not limited to: colorectal, general surgery, OBGYN, urology, vascular, neurosurgery and other procedures.
- the incisions or wounds closed following their respective surgeries are susceptible to high infection rates and slow patient recovery periods which also impact the physician, staff, hospital, insurer, etc.
- SSI costs hospitals billions of dollars every year in the U.S. and insurance companies do not reimburse hospitals for maladies caused by infection, and corresponding complications, due to surgical site infection.
- a wound healing device for applying within an incision or wound comprises: a first portion (e.g., a dressing, bandage, etc.) that is applied over the incision or wound (e.g., open or closed), wherein the first portion comprises a fluid absorbent material (e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.); a second portion (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) that is in fluid communication and comprises a fluid absorbent material or materials material (e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.) with the first portion at a first end of the second portion and a second end of the second portion that is positioned within the wound in the subcutaneous skin layer, wherein the second portion comprises a fluid absorbent material (e.g., any natural or synthetic material, such but not limited to cotton, nylon, packing
- a method for wound healing that greatly reduces the chances for infection of an incision or wound (e.g., open or closed) of a patient is disclosed.
- the method comprises: inserting one end of at least one fluid absorbing material (e.g., any natural or synthetic material, such but not limited to cotton, Teflon, nylon, packing material, etc.) inside the incision or wound; positioning a second end of said at least one fluid absorbing material (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) which in itself permits the inclusion of air into the incision, to be in fluid communication with another fluid absorbent material (e.g., a dressing, bandage, etc.
- a fluid absorbent material e.g., a dressing, bandage, etc.
- any natural or synthetic material such but not limited to cotton, Teflon, nylon, packing material, etc.
- any natural or synthetic material such but not limited to cotton, Teflon, nylon, packing material, etc.
- the at least one fluid absorbing material and said another fluid absorbent material within and top of the incision or wound respectively, for approximately 1-3 days for conveying fluid out of the incision or wound and into the another fluid absorbent material.
- a wound healing device for applying within an incision or wound (e.g., open or closed) is disclosed.
- the wound healing device comprises: at least one fluid absorbent material (e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.) formed into a strand (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) having a first end that is positioned within the wound or incision in the subcutaneous skin layer and wherein the strand further comprises a second free end that protrudes out of the wound or incision.
- a fluid absorbent material e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.
- a strand e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.
- a method for wound healing that greatly reduces the chances for infection of an incision or wound (e.g., open or closed) of a patient is disclosed.
- the method comprises: forming at least one strand of a fluid absorbing material (e.g., any natural or synthetic material, such but not limited to cotton, Teflon, nylon, packing material, etc.); inserting a first end of said at least one strand (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) inside the incision or wound; positioning a second free end of said at least one strand to be positioned external of the patient; and maintaining said first end of said at least one strand within the incision or wound for approximately 1-3 days for conveying fluid out of the incision or wound and into said strand.
- a fluid absorbing material e.g., any natural or synthetic material, such but not limited to cotton, Teflon, nylon, packing material, etc.
- a first end of said at least one strand e.g.
- FIG. 1 A is bottom view of the wound healing device of the present invention
- FIG. 1 B is a side view of the wound healing device of the present invention.
- FIG. 1 C is top view of the wound healing device
- FIG. 2 A is a functional diagram of the wound healing device in place in the closed incision or wound (e.g., in a patient's abdominal wall);
- FIG. 2 B is a functional diagram of the closed incision following the removal of the wound healing device, showing the formation of type of fistulae in the subcutaneous tissue;
- FIG. 3 A is a second more simplified embodiment of the wound healing device
- FIG. 3 B is bottom view of the second embodiment
- FIG. 3 C is a top view of the second embodiment
- FIGS. 4 A- 4 M depict a surgeon or other healthcare technician applying the wound healing device of the present invention
- FIG. 5 depicts a third embodiment of the present invention which uses a continuous loop for the absorbent member that is disposed in the wound;
- FIG. 6 depicts a fourth embodiment that uses a packing strip for the dressing and to which the absorbent members are coupled;
- FIG. 7 depicts a fifth embodiment that uses a packing strip for the dressing and to which a continuous loop absorbent member is coupled;
- FIG. 8 depicts a sixth embodiment of the present invention that uses extendable absorbent members fed from respective dispensers on or from within the dressing;
- FIG. 9 depicts a seventh embodiment of the present invention that also uses extendable absorbent members that have extensions in the form of loops that pass through the present invention
- FIG. 9 A depicts a variation of the seventh embodiment of the present invention that also uses extendable absorbent members that have extensions in the form of loops that are positioned within the bandage portion of the present invention
- FIG. 10 depicts an eighth embodiment of the present invention that also uses extendable absorbent members wherein the extensions are formed from excess material formed into loops on the absorbent members;
- FIG. 11 depicts a ninth embodiment of the present invention wherein the absorbent member comprises foldable component that can be expanded into the wound once the absorbent member is passed into the closed incision;
- FIG. 12 depicts a tenth embodiment of the present invention wherein the absorbent members are not in direct contact with the dressing but wherein fluids absorbed into the absorbent members can jump or leap into the dressing;
- FIG. 13 depicts an eleventh embodiment of the present invention wherein the absorbent members are positioned within the wound without any coupling to a dressing and to which at a later stage a dressing may or may not be placed into contact with the portion of the absorbent members that extends out of the wound;
- FIG. 14 is a functional diagram of the wound healing device in place in an open incision or wound (e.g., in a patient's abdominal wall);
- FIG. 15 is a plan view of the dressing of another variation of the wound healing device that includes a cutaway along its edge to accommodate an obstruction, such as a stoma, closely adjacent the incision or wound; and
- FIG. 15 A is a plan view of a further embodiment of the wound healing device that includes an opening in the dressing that permits an obstruction to pass through the dressing to permit the dressing to make sufficient contact with the skin when the incision or wound is closely adjacent the obstruction.
- the wound healing device (WHD) 20 of the present application absorbs fluid from all three layers of skin, removes fluid where infection is most common—along the incision.
- the WHD 20 does not clog, does not involve making additional holes in patient and exhibits the highest success rate of any infection reduction system on the highest infection risk patients —patients with multiple additional high risk factors including but not limited to: contaminated incision, diabetes, and malnutrition.
- the WHD 20 is a complete fluid absorption system.
- the WHD 20 is completely removed from the patient without re-stitching or stapling usually two days following surgery. In many patients once the WHD 20 is removed, no other dressings are necessary. In most cases where an additional light dressing is required, it is usually removed within another day or two.
- the WHD 20 is the only device that absorbs fluid and infectious materials at the source during and after the source has formed and the WHD 20 moves the fluid and materials out of the body.
- Recent data using the WHD 20 cites the infection rate using at 4.2% and in cases where infection did occur, the infection was less severe and covered a smaller area.
- This data is virtually identical to the probe techniques studies where the patient's wound is cleaned daily with a deep insertion of cotton swabs, for five days following surgery.
- the probe methodology data is very similar to that related to the WHD 20 ; with infection rates of 3% and 4% and patients' hospital stays being reduced from 7 to 5 days, per patient.
- the probe technique is highly effective, it still requires daily cleaning of wound by physician for five days, and involves significant patient discomfort. It is a labor intensive solution.
- the WHD 20 offers virtually identical results, using very similar concept but without the need of extensive physician labor, potentially high patient discomfort and mental anguish and still only removes the fluid and potentially infectious material after it has collected subcutaneously.
- the preferred embodiment of the WHD 20 comprises a first portion 22 that is positioned on top of the patient's skin over the wound.
- This first portion 22 may referred to as a “dressing”.
- the dressing 22 may comprise any material, either natural or synthetic, or a combination, that can absorb fluids; for example, but not limited to, cotton, Teflon, nylon, packing material, etc.
- FIG. 1 A depicts the dressing 22 as comprising a rounded rectangular shape, the dressing 22 is not limited to that shape and may assume any shape or size but as long as it comprises a fluid-absorbing characteristic.
- the dressing 22 may comprise a single layer or multi-layered construction, and may also be in combination with the use of non-adhering and/or medicated bandage materials and/or materials that control the direction of wicking of liquids.
- a second portion 24 In fluid communication with the first portion 22 is a second portion 24 that may comprise at least strip 24 that also comprises a fluid-absorbing characteristic.
- This second portion or strip 24 may comprise a single element of fluid-absorbing characteristic or it may comprise a looped construction, such as that shown by 24 A in FIG. 1 A .
- the physical construction of the strip 24 can vary and can be referred to using any number of terms, such as but not limited to, strip, loop, tab, cord, appendage, tentacle, finger, etc. but as long as the strip 24 comprises a fluid-absorbing characteristic.
- the composition of the strip 24 may comprise any natural or synthetic material such as, but not limited to, cotton, nylon, etc. By way of example only, six strips 24 are shown in fluid communication with the first portion 22 .
- each of the second portion or strips 24 may comprise a tong-like, or comb-like, form to guide or assist in placing or positioning them within in an open or closed wound or incision.
- the fluid communication of the second portion 24 to the first portion 22 can be achieved in several ways, one of which is by stitching or via any other method of physically-connecting the first 22 and a first end 25 A of the second portion 24 , as shown by way of example only in FIG. 1 A .
- the length of the second portion 24 is approximately 2-3 inches, although the length could vary to 4 inches or even 8 inches, depending upon the size of the patient.
- FIGS. 3 A- 3 C shown a second, more simplified version of the WHD 20 A wherein the first portion 22 comprises a swath of gauze that can be folded into a multi-layer construction and then closed 33 (e.g., stitched) to avoid the first portion 22 from unraveling.
- the WHD 20 A operates in the same manner as the WHD 20 .
- FIG. 2 A depicts a functional diagram of how the WHD 20 / 20 A works when installed in the wound of the patient.
- the surgeon or other healthcare attendant pushes each strip 24 through a portion of the closed incision, in between the wound staples or sutures.
- the WHD 20 / 20 A shown in FIG. 2 A shows the invention with six strips 24 positioned deep inside the closed incision 15 and positioned in the subcutaneous layer tissue 16 above the muscle 18 .
- the first portion (dressing) 22 is positioned on the outer skin 14 directly over the closed incision 15 . Fluids that form in this layer are absorbed by the strips 24 and are drawn upward, as shown by arrows 32 , out of the skin layers 14 / 16 and into the first portion (dressing) 22 . By removing fluid from these skin layers immediately, the chances for infection are greatly reduced.
- fistulae 34 continue to drain fluid upward towards the conventional bandage, thereby removing even more fluid from the subcutaneous layer 16 .
- these type of fistulae 34 naturally close, from the bottom upward, after a few additional days (e.g., 1-2 days) following the removal of the apparatus but they facilitate in draining the subcutaneous layer 16 even more.
- the WHD 20 / 20 A also provides temporary draining channels for such fluid that are not formed in the subcutaneous layer 16 by other conventional draining equipment.
- These types of fistulae 34 serve as a natural drainage system that work in conjunction with the patient's normal healing process and the subsequent closure of the fistula.
- FIGS. 4 A- 4 M depict an exemplary WHD 20 / 20 A application process. Although these figures show the use of only two loops 24 A, it should be understood that this is simply by way of example and that just one, or more than two strips/loops could be used.
- the wound and subject area 15 may be contaminated or clean contaminated or infected wound in which liquid may accumulate and/or colonize bacteriologically, collecting from any and or all layers.
- the absorbent dressing 22 is located on the surface of the wound 15 and subject area. Transfer of liquid and waste material from the wound and subject area to the dressing 22 is realized by capillary transfer and any other method of transfer of the absorbent strip, loop, cord or tube or appendage 24 connected or adjacent to the dressing 22 to facilitate the transfer of liquid and material from the wound area dressing 22 is provided with one or more strip, loop, cord or tube or appendage 24 which is, or is located in the area of the wound 15 , infected or potentially infected area and therefore facilitates the flow of liquid and bodily waste materials from the subcutaneous 16 to the dressing absorbent material 22 outside the patient body.
- FIG. 4 A shows a wound 15 in the skin 14 closed with staples 17 , where gaps 19 between the staples 17 allow the passage of the strips 24 , as discussed below; the extreme end (i.e., second end 25 B) of one strip 24 can be seen at the top of FIG. 4 A , being moved over a surgical covering 11 .
- FIG. 4 B depicts the WHD 20 / 20 A being positioned over the wound 15 (not visible in FIG. 4 B ); it should be noted that the WHD 20 / 20 A includes an adhesive border (not shown) which is covered by a release border 36 along the edge of the first portion 22 .
- FIG. 4 C shows the surgeon or other healthcare attendant manipulating the WHD 20 / 20 A such that one of the strips 24 is positioned over a gap 19 between staples 17 .
- FIG. 4 D shows the surgeon or healthcare attendant (hereinafter “surgeon”) further manipulating the WHD 20 / 20 A in order to properly position one of the strips 24 over a gap 19 in the wound 15 between staples 17 .
- FIG. 4 E shows the surgeon seizing one of the strips 24 with a clamp 2 in preparation to push the strip 24 into the gap 19 ; in FIG. 4 F , the surgeon is pushing the free end of the strip 24 into a gap 19 in the wound 15 .
- FIGS. 4 G- 4 H shows the surgeon inserting another strip 24 into another gap 19 in the wound 15 .
- the surgeon pushes the free end of the strip 24 down into the gap 19 and obtains a tactile indication to stop when the surgeon feels contact with the fascia layer is made.
- FIG. 4 I shows both strips 24 pushed down into respective gaps 19 in the wound 15 between staples 17 .
- FIGS. 4 J- 4 K show the surgeon applying the first portion 22 onto the skin 14 and then removes the release liner 36 from the first portion 22 .
- FIG. 4 M depicts the WHD 20 / 20 A releasably secured in place in and over the wound 15 .
- a transparent adhesive 37 overlays the top surface of the dressing 22 (and to which the release liner 36 was originally attached) that releasably secures the dressing 22 to the skin 14 .
- FIG. 5 depicts a third embodiment of the WHD 20 B wherein the at least one strip 24 is replaced by a continuous absorbent member 24 B that is formed into a large loop.
- the loop 24 B comprises ends that correspond to ends of the first portion 22 .
- FIG. 6 depicts a fourth embodiment of the WHD 20 C wherein the first portion 22 is formed of a thin packing material 22 A.
- FIG. 7 depicts a fifth embodiment of the WHD 20 D which is a combination of the third and fourth embodiments.
- the first portion 22 A is formed of a thin packing material 22 A and the at least one strip 24 comprises the large loop 24 B.
- the WHD 20 D comprises the loop 24 having ends that correspond to the ends of the first portion 22 .
- Another key improvement to the WHD 20 / 20 A is the ability to extend the length of the at least one strip 24 A. This can be advantageous for a number of reasons. Allowing the surgeon to adjust the length of the at least one strip 24 permits the surgeon to customize the absorbing capability of the present invention 20 based on the patient's physiology. If, by way of example, the patient has a large girth, it may be necessary to extend the length of the at least one strip 24 , deeper into the subcutaneous layer 16 .
- FIG. 8 depicts a sixth embodiment 20 E wherein respective cartridges 38 of strip material permit the strips 24 to be extended to new lengths 24 ′, shown in phantom.
- FIG. 9 shows the use of “slack loops” 40 in a seventh embodiment 20 F that project from the upper side of the first portion 22 .
- the surgeon can push downward on each strip 24 to extend the length of each strip to that shown by 24 ′′ by a corresponding decrease 40 ′ in the slack loops 40 .
- FIG. 9 A shows an exemplary embodiment 20 F 1 where the “slack loops” are provided within the first portion 22 itself.
- the arrow indicates movement as the strip 24 is lengthened and the slack loops 40 are shortened.
- FIG. 10 depicts an eighth embodiment 20 G that uses “slip knots” 42 in each strip 24 that allow each strip 24 to be lengthened by applying a downward force on each strip 24 ; excess material formed in the slip know 42 permits the respective strip 24 to be lengthened 42 ′.
- FIG. 11 depicts a ninth embodiment 20 H wherein the second portion 24 C comprises a foldable portion 44 that can be expanded outward within the subcutaneous layer 16 once the second portion 24 C is passed through a gap 19 in the wound 15 .
- the surgeon can then expand the foldable portion 44 along the length of the wound 15 within the subcutaneous layer 16 .
- a further variation 20 J of the present invention 20 is the use of free absorbent members 24 being placed into the wound in between the staples or sutures 17 , wherein the upper ends 24 C of the absorbent members are free, as shown most clearly in FIG. 13 .
- the surgeon or other healthcare technician can insert each of these free absorbent members 24 in between the sutures or staples 17 in the subcutaneous layer tissue 16 above the muscle 18 , as described previously.
- these free absorbent members 24 may remain in the wound for approximately 1-3 days at which time they are then removed by the surgeon or other healthcare technician.
- fluids that form in the wound are absorbed by the strips 24 and are drawn upward, out of the skin layers 14 / 16 .
- fistulae 34 are also formed as described earlier with regard to FIG. 2 .
- a separate dressing 22 may also be applied to the upper ends 24 C during the time the free absorbent members 24 inserted into the wound, although this is not required.
- the WHD 20 is placed inside an open wound, i.e., where no sutures or staples are used to close the wound.
- the surgeon places the strips 24 down into the open wound with the dressing 22 being placed at the skin level.
- the variation 20 J discussed previously can be placed also into the open wound and then a separate dressing 22 may be placed in contact with the upper ends 24 C of the free absorbent members 24 .
- FIGS. 15 and 15 A provide further embodiments of the WHD to accommodate surrounding items or obstructions at the skin surface that would prevent the dressing 22 from making good contact with the skin surface.
- FIG. 15 depicts a top view of this additional WHD embodiment 20 K whose first portion 22 comprises a dressing edge removed, forming a cutaway 46 .
- the WHD embodiment 20 K can be positioned as described previously and the dressing 20 can be positioned such that the cutaway 46 is positioned closely adjacent the stoma/tube, thereby allowing the edges of the dressing 22 of the WHD 20 K to make good contact with the skin surface and not be interfered with by the stoma/tube.
- the shape of the cutaway 46 is by way of example only and it is not limited to a semi-circular contour but may comprise any shape and size.
- the relative position of the cutaway 46 can be located along any edge of the dressing 22 .
- FIG. 15 A shows another embodiment 20 L of the WHD wherein an interior portion forming an opening 48 of the dressing 22 is removed.
- the obstruction e.g., a stoma, a tube, a medical device or sensor, etc.
- the opening 48 is shown by way of example only; other shapes and other locations on the dressing 22 may comprise the opening 48 .
- an anti-microbial composition may be applied to either the first portion 22 and/or the second portion 24 .
- the present invention relates to an apparatus/method of wound infection prevention and healing acceleration and life.
- the WHD 20 provides the effective post-surgical clean contaminated, contaminated, clean and infected incision when the rate of infection potential is considered significant.
- the apparatus/method may also be used in a variety of medical surgeries interventions and procedures.
- the present invention 20 can also be used in veterinary medicine.
- the apparatus & method for wound infection device (WHD) 20 is useful for preventing SSI infection for the following surgeries including but is not limited to: general surgery procedures, colorectal, OBGYN procedures, urology, vascular surgeries, and neurosurgery procedures.
- the incisions or wounds closed following their respective surgeries are susceptible to high infection rates and slow patient recovery periods which also impact the physician, staff, hospital, insurer, etc.
- SSI costs hospitals billions of dollars every year in the U.S. and insurance companies do not reimburse hospitals for maladies caused by infection, and corresponding complications, due to surgical site infection.
- WHD includes any all of kinds of kits that comprise the WHD and any associated components (e.g., a plurality of WHDs; tools that may be used by the surgeon to insert the second portion 24 into wound site (e.g., pliers, tweezers, dissectors, etc.) that are provided with the WHD 20 itself.
- any associated components e.g., a plurality of WHDs; tools that may be used by the surgeon to insert the second portion 24 into wound site (e.g., pliers, tweezers, dissectors, etc.) that are provided with the WHD 20 itself.
- the apparatus and method for wound infection device (WHD) 20 accelerates the healing process by reducing the healing time by an average of 2 days per patient, which among other things, reduces hospital stay periods.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Materials For Medical Uses (AREA)
- Media Introduction/Drainage Providing Device (AREA)
Abstract
A wound healing device and method that greatly reduces the risk of infection of an incision or wound by removing fluid from the subcutaneous skin layers. The wound healing device includes a first portion that is positioned external of, and on top of, the wound. At least one strip, cord, finger, member is in fluid communication at one end with the first portion while the second free end of the at least one strip, cord, finger, member is pushed down into the wound, in between the sutures or staples of a closed incision. Both the first portion and the at least one strip comprise fluid absorbable material for absorbing the wound fluid. The device remains in place for approximately 1-3 days after which it is removed. Upon removal, natural temporary “type of fistulae” are formed in the subcutaneous skin layers to continue draining wound fluids upward for another 1-2 days.
Description
- This nonprovisional application is co-pending with and continuation of U.S. patent application Ser. No. 16/148,876 filed on Oct. 1, 2018 entitled APPARATUS FOR WOUND INFECTION PREVENTION. U.S. patent application Ser. No. 16/148,876 was co-pending with and continuation of U.S. patent application Ser. No. 14/193,584 filed on Feb. 28, 2014 entitled APPARATUS & METHOD FOR WOUND INFECTION PREVENTION. U.S. patent application Ser. No. 14/193,584 was co-pending with and claims benefit of both U.S. Prov. Pat. App. No. 61/774,272 filed on Mar. 7, 2013 entitled METHOD OF WOUND INFECTION PREVENTION AND CLEAN KIT and U.S. Prov. Pat. App. No. 61/914,720 filed on Dec. 11, 2013 entitled APPARATUS AND METHOD FOR WOUND INFECTION PREVENTION. This nonprovisional patent application claims priority to U.S. patent application Ser. No. 16/148,876, U.S. patent application Ser. No. 14/193,584, U.S. Prov. Pat. App. No. 61/774,272, and U.S. Prov. Pat. App. No. 61/914,720. All the entire disclosures of the patent applications are incorporated by reference herein.
- The present invention relates generally to apparatus and methods for treating wounds, and more particularly, to an apparatus and method for healing closed incisions following surgery.
- America wastes over a billion dollars annually, on post-operative surgical site infection expenses. These surgeries have an acknowledged overall infection rate of between 15%-30%. Surgical site infection slows the recovery rate for patients and adds additional health costs with prolonged hospital treatment, additional home care, physician office and emergency room visits expenses.
- Typically, physicians often respond to the risk of wound infection with the “open wound” technique, subjecting patients to psychological torment of the patient knowing they have an open wound, restricting them from normal activity. The patient is left with a hole in their body open to the outside; which requires additional health maintenance including additional dressing changes by visiting nurses, additional physician consultation and additional high cost of vacuum device usually for a week or longer.
- Physicians, attempts to avoid an open wound, will often install a drainage device in the patient. This is accomplished by placing a plastic tube into the patient, horizontally along the fascia layer and closing the wound around the tube. The most common drains; the “J-Drain”, and “Penrose Drain”, do not remove fluid from all three layers of skin, have a tendency to clog up and can even increase the production of additional fluid in patients; at times making the infection and recovery issues worse. The drains must then eventually be removed by surgeon, sometimes weeks after surgery. Research shows these drains have a poor rate of success with some studies showing an actual increase in patient complications.
- Patients enduring the traditional old fashioned healing systems frequently require weeks to recover, extensive follow-up treatments and procedures and have increased the risk of complications and even death.
- Recently, open wound “negative pressure” treatments are now also being touted as the answer for closed incision as well as open wound infection preventative treatments; this treatment simply removes excess fluid from cutaneous areas from the outer skin level. Negative pressure treatments fail to effectively address the underlining cause of surgical site infection (SSI) in closed incisions. The negative pressure VAC (vacuum) systems are also very expensive and are physician and nurse-labor intensive. The data surrounding the VAC systems appears to be mixed and studies appear to show that these systems involve patients with fewer high risk factors prior to surgery.
- SSI infections may occur from the following, but not limited to: colorectal, general surgery, OBGYN, urology, vascular, neurosurgery and other procedures. The incisions or wounds closed following their respective surgeries are susceptible to high infection rates and slow patient recovery periods which also impact the physician, staff, hospital, insurer, etc. Moreover, SSI costs hospitals billions of dollars every year in the U.S. and insurance companies do not reimburse hospitals for maladies caused by infection, and corresponding complications, due to surgical site infection.
- Thus, there remains a need for an apparatus and associated method that enables the physician to close the wound without significantly increasing the risk of surgical site infection to the patient, thereby being able to safely close more patients following surgery and improving their lives. The apparatus and associated method is easy to remove from the patient and is a cost effective solution.
- All references cited herein are incorporated herein by reference in their entireties.
- A wound healing device for applying within an incision or wound is disclosed. The wound healing device comprises: a first portion (e.g., a dressing, bandage, etc.) that is applied over the incision or wound (e.g., open or closed), wherein the first portion comprises a fluid absorbent material (e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.); a second portion (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) that is in fluid communication and comprises a fluid absorbent material or materials material (e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.) with the first portion at a first end of the second portion and a second end of the second portion that is positioned within the wound in the subcutaneous skin layer, wherein the second portion comprises a fluid absorbent material (e.g., any natural or synthetic material, such but not limited to cotton, nylon, packing material, etc.).
- A method for wound healing that greatly reduces the chances for infection of an incision or wound (e.g., open or closed) of a patient is disclosed. The method comprises: inserting one end of at least one fluid absorbing material (e.g., any natural or synthetic material, such but not limited to cotton, Teflon, nylon, packing material, etc.) inside the incision or wound; positioning a second end of said at least one fluid absorbing material (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) which in itself permits the inclusion of air into the incision, to be in fluid communication with another fluid absorbent material (e.g., a dressing, bandage, etc. and also comprising any natural or synthetic material, such but not limited to cotton, Teflon, nylon, packing material, etc.) that is positioned external of the patient and over top of the incision or wound; and maintaining said at least one fluid absorbing material and said another fluid absorbent material within and top of the incision or wound respectively, for approximately 1-3 days for conveying fluid out of the incision or wound and into the another fluid absorbent material. Because of the communication between the (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) and the outer dressing, the (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) cannot be accidentally left inside the patient.
- A wound healing device for applying within an incision or wound (e.g., open or closed) is disclosed. The wound healing device comprises: at least one fluid absorbent material (e.g., any natural or synthetic material, such but not limited to: cotton, Teflon, nylon, packing material, etc.) formed into a strand (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) having a first end that is positioned within the wound or incision in the subcutaneous skin layer and wherein the strand further comprises a second free end that protrudes out of the wound or incision.
- A method for wound healing that greatly reduces the chances for infection of an incision or wound (e.g., open or closed) of a patient is disclosed. The method comprises: forming at least one strand of a fluid absorbing material (e.g., any natural or synthetic material, such but not limited to cotton, Teflon, nylon, packing material, etc.); inserting a first end of said at least one strand (e.g., strip, loop, tab, cord, appendage, tentacle, finger, etc.) inside the incision or wound; positioning a second free end of said at least one strand to be positioned external of the patient; and maintaining said first end of said at least one strand within the incision or wound for approximately 1-3 days for conveying fluid out of the incision or wound and into said strand.
- Many aspects of the present disclosure can be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis instead being placed upon clearly illustrating the principles of the present disclosure. Moreover, in the drawings, like reference numerals designate corresponding parts throughout the several views.
-
FIG. 1A is bottom view of the wound healing device of the present invention; -
FIG. 1B is a side view of the wound healing device of the present invention; -
FIG. 1C is top view of the wound healing device; -
FIG. 2A is a functional diagram of the wound healing device in place in the closed incision or wound (e.g., in a patient's abdominal wall); -
FIG. 2B is a functional diagram of the closed incision following the removal of the wound healing device, showing the formation of type of fistulae in the subcutaneous tissue; -
FIG. 3A is a second more simplified embodiment of the wound healing device; -
FIG. 3B is bottom view of the second embodiment; -
FIG. 3C is a top view of the second embodiment; -
FIGS. 4A-4M depict a surgeon or other healthcare technician applying the wound healing device of the present invention; -
FIG. 5 depicts a third embodiment of the present invention which uses a continuous loop for the absorbent member that is disposed in the wound; -
FIG. 6 depicts a fourth embodiment that uses a packing strip for the dressing and to which the absorbent members are coupled; -
FIG. 7 depicts a fifth embodiment that uses a packing strip for the dressing and to which a continuous loop absorbent member is coupled; -
FIG. 8 depicts a sixth embodiment of the present invention that uses extendable absorbent members fed from respective dispensers on or from within the dressing; -
FIG. 9 depicts a seventh embodiment of the present invention that also uses extendable absorbent members that have extensions in the form of loops that pass through the present invention; -
FIG. 9A depicts a variation of the seventh embodiment of the present invention that also uses extendable absorbent members that have extensions in the form of loops that are positioned within the bandage portion of the present invention; -
FIG. 10 depicts an eighth embodiment of the present invention that also uses extendable absorbent members wherein the extensions are formed from excess material formed into loops on the absorbent members; -
FIG. 11 depicts a ninth embodiment of the present invention wherein the absorbent member comprises foldable component that can be expanded into the wound once the absorbent member is passed into the closed incision; -
FIG. 12 depicts a tenth embodiment of the present invention wherein the absorbent members are not in direct contact with the dressing but wherein fluids absorbed into the absorbent members can jump or leap into the dressing; -
FIG. 13 depicts an eleventh embodiment of the present invention wherein the absorbent members are positioned within the wound without any coupling to a dressing and to which at a later stage a dressing may or may not be placed into contact with the portion of the absorbent members that extends out of the wound; -
FIG. 14 is a functional diagram of the wound healing device in place in an open incision or wound (e.g., in a patient's abdominal wall); -
FIG. 15 is a plan view of the dressing of another variation of the wound healing device that includes a cutaway along its edge to accommodate an obstruction, such as a stoma, closely adjacent the incision or wound; and -
FIG. 15A is a plan view of a further embodiment of the wound healing device that includes an opening in the dressing that permits an obstruction to pass through the dressing to permit the dressing to make sufficient contact with the skin when the incision or wound is closely adjacent the obstruction. - Referring now to the figures, wherein like reference numerals represent like parts throughout the several views, exemplary embodiments of the present disclosure will be described in detail. Throughout this description, various components may be identified having specific values, these values are provided as exemplary embodiments and should not be limiting of various concepts of the present invention as many comparable sizes and/or values may be implemented.
- The wound healing device (WHD) 20 of the present application absorbs fluid from all three layers of skin, removes fluid where infection is most common—along the incision. The
WHD 20 does not clog, does not involve making additional holes in patient and exhibits the highest success rate of any infection reduction system on the highest infection risk patients —patients with multiple additional high risk factors including but not limited to: contaminated incision, diabetes, and malnutrition. As will be discussed in detail, theWHD 20 is a complete fluid absorption system. - As will also be discussed below, the
WHD 20 is completely removed from the patient without re-stitching or stapling usually two days following surgery. In many patients once theWHD 20 is removed, no other dressings are necessary. In most cases where an additional light dressing is required, it is usually removed within another day or two. - One of the key features of the
WHD 20, as will also be discussed below, is that it is the only device that absorbs fluid and infectious materials at the source during and after the source has formed and theWHD 20 moves the fluid and materials out of the body. Recent data using theWHD 20 cites the infection rate using at 4.2% and in cases where infection did occur, the infection was less severe and covered a smaller area. This data is virtually identical to the probe techniques studies where the patient's wound is cleaned daily with a deep insertion of cotton swabs, for five days following surgery. The probe methodology data is very similar to that related to theWHD 20; with infection rates of 3% and 4% and patients' hospital stays being reduced from 7 to 5 days, per patient. However, even though the probe technique is highly effective, it still requires daily cleaning of wound by physician for five days, and involves significant patient discomfort. It is a labor intensive solution. In contrast, theWHD 20 offers virtually identical results, using very similar concept but without the need of extensive physician labor, potentially high patient discomfort and mental anguish and still only removes the fluid and potentially infectious material after it has collected subcutaneously. - The preferred embodiment of the WHD 20 (see
FIGS. 1A-1C ) comprises afirst portion 22 that is positioned on top of the patient's skin over the wound. Thisfirst portion 22 may referred to as a “dressing”. The dressing 22 may comprise any material, either natural or synthetic, or a combination, that can absorb fluids; for example, but not limited to, cotton, Teflon, nylon, packing material, etc. AlthoughFIG. 1A depicts the dressing 22 as comprising a rounded rectangular shape, the dressing 22 is not limited to that shape and may assume any shape or size but as long as it comprises a fluid-absorbing characteristic. The dressing 22 may comprise a single layer or multi-layered construction, and may also be in combination with the use of non-adhering and/or medicated bandage materials and/or materials that control the direction of wicking of liquids. - In fluid communication with the
first portion 22 is asecond portion 24 that may comprise atleast strip 24 that also comprises a fluid-absorbing characteristic. This second portion orstrip 24 may comprise a single element of fluid-absorbing characteristic or it may comprise a looped construction, such as that shown by 24A inFIG. 1A . It should be understood that the physical construction of thestrip 24 can vary and can be referred to using any number of terms, such as but not limited to, strip, loop, tab, cord, appendage, tentacle, finger, etc. but as long as thestrip 24 comprises a fluid-absorbing characteristic. The composition of thestrip 24 may comprise any natural or synthetic material such as, but not limited to, cotton, nylon, etc. By way of example only, sixstrips 24 are shown in fluid communication with thefirst portion 22. It is also within the broadest scope of the invention to include materials that control the direction of wicking of liquids. This may also be in combination with the use of non-adhering and/or medicated bandage materials. Moreover, it also within the broadest scope of the invention wherein each of the second portion or strips 24 may comprise a tong-like, or comb-like, form to guide or assist in placing or positioning them within in an open or closed wound or incision. - The fluid communication of the
second portion 24 to thefirst portion 22 can be achieved in several ways, one of which is by stitching or via any other method of physically-connecting the first 22 and afirst end 25A of thesecond portion 24, as shown by way of example only inFIG. 1A . However, it is within the broadest scope of thepresent invention 20 to include the conveyance of fluid from thesecond portion 24 into the first 22 by way of the fluid “wicking” across a slight gap between an end of thesecond portion 24 and thefirst portion 22. This is shown most clearly inFIG. 12 wherefluid 12 absorbed into thesecond portion 24 “leaps” or “jumps” from the extreme end of thesecond portion 24 through aspacer 31, that physically separates thesecond portion 24 from thefirst portion 22, and is finally absorbed into thefirst portion 22. Thus, the useabsorbent members 24 that are not directly in contact with thebandage 22 are within the broadest scope of theinvention 20. - The length of the
second portion 24 is approximately 2-3 inches, although the length could vary to 4 inches or even 8 inches, depending upon the size of the patient. -
FIGS. 3A-3C shown a second, more simplified version of theWHD 20A wherein thefirst portion 22 comprises a swath of gauze that can be folded into a multi-layer construction and then closed 33 (e.g., stitched) to avoid thefirst portion 22 from unraveling. Other than that, theWHD 20A operates in the same manner as theWHD 20. -
FIG. 2A depicts a functional diagram of how theWHD 20/20A works when installed in the wound of the patient. In particular, the surgeon or other healthcare attendant pushes eachstrip 24 through a portion of the closed incision, in between the wound staples or sutures. By way of example only, theWHD 20/20A shown inFIG. 2A shows the invention with sixstrips 24 positioned deep inside theclosed incision 15 and positioned in thesubcutaneous layer tissue 16 above themuscle 18. The first portion (dressing) 22 is positioned on theouter skin 14 directly over theclosed incision 15. Fluids that form in this layer are absorbed by thestrips 24 and are drawn upward, as shown byarrows 32, out of the skin layers 14/16 and into the first portion (dressing) 22. By removing fluid from these skin layers immediately, the chances for infection are greatly reduced. - Moreover, upon removal of the
WHD 20/20A from the wound in approximately 1-3 days, removal of thestrips 24 leaves behind respective “type of fistulae” 34 (seeFIG. 2B ) within thesubcutaneous skin 16 andskin 14 layers. These type of fistulae provide temporary “channels” that permit fluid in thesubcutaneous layer 16 to continue to escape upward for a finite time, after removal of theWHD 20/20A, further draining thislayer 16 of fluid, and allowing air to enter the wound. In particular, once theWHD 20/20A is removed from thewound 15, a conventional bandage (not shown) is placed over thewound 15. These types offistulae 34 continue to drain fluid upward towards the conventional bandage, thereby removing even more fluid from thesubcutaneous layer 16. Eventually, these type offistulae 34 naturally close, from the bottom upward, after a few additional days (e.g., 1-2 days) following the removal of the apparatus but they facilitate in draining thesubcutaneous layer 16 even more. Thus, theWHD 20/20A also provides temporary draining channels for such fluid that are not formed in thesubcutaneous layer 16 by other conventional draining equipment. These types offistulae 34 serve as a natural drainage system that work in conjunction with the patient's normal healing process and the subsequent closure of the fistula. -
FIGS. 4A-4M depict anexemplary WHD 20/20A application process. Although these figures show the use of only twoloops 24A, it should be understood that this is simply by way of example and that just one, or more than two strips/loops could be used. - After the surgery, in the domain of sutures or
staples 17 of theskin 14 of the subcutaneous, of the subcutaneous 16, and of the fascia, the wound andsubject area 15, may be contaminated or clean contaminated or infected wound in which liquid may accumulate and/or colonize bacteriologically, collecting from any and or all layers. - As mentioned earlier, the
absorbent dressing 22 is located on the surface of thewound 15 and subject area. Transfer of liquid and waste material from the wound and subject area to the dressing 22 is realized by capillary transfer and any other method of transfer of the absorbent strip, loop, cord or tube orappendage 24 connected or adjacent to the dressing 22 to facilitate the transfer of liquid and material from the wound area dressing 22 is provided with one or more strip, loop, cord or tube orappendage 24 which is, or is located in the area of thewound 15, infected or potentially infected area and therefore facilitates the flow of liquid and bodily waste materials from the subcutaneous 16 to the dressingabsorbent material 22 outside the patient body. - The facilitation of the liquid and bodily materials especially from the incision wound 15, infected or potentially infected area or injury area, from potentially any and all subcutaneous areas and
levels 16, into absorbent or liquid extractable strips, loops, cords, tubes orabsorbent appendage 24 towards and into the adjacent or attached absorbent materials external to the body. - In particular,
FIG. 4A shows awound 15 in theskin 14 closed withstaples 17, wheregaps 19 between thestaples 17 allow the passage of thestrips 24, as discussed below; the extreme end (i.e., second end 25B) of onestrip 24 can be seen at the top ofFIG. 4A , being moved over asurgical covering 11. -
FIG. 4B depicts theWHD 20/20A being positioned over the wound 15 (not visible inFIG. 4B ); it should be noted that theWHD 20/20A includes an adhesive border (not shown) which is covered by arelease border 36 along the edge of thefirst portion 22. -
FIG. 4C shows the surgeon or other healthcare attendant manipulating theWHD 20/20A such that one of thestrips 24 is positioned over agap 19 betweenstaples 17.FIG. 4D shows the surgeon or healthcare attendant (hereinafter “surgeon”) further manipulating theWHD 20/20A in order to properly position one of thestrips 24 over agap 19 in thewound 15 betweenstaples 17.FIG. 4E shows the surgeon seizing one of thestrips 24 with aclamp 2 in preparation to push thestrip 24 into thegap 19; inFIG. 4F , the surgeon is pushing the free end of thestrip 24 into agap 19 in thewound 15. -
FIGS. 4G-4H shows the surgeon inserting anotherstrip 24 into anothergap 19 in thewound 15. Typically, the surgeon pushes the free end of thestrip 24 down into thegap 19 and obtains a tactile indication to stop when the surgeon feels contact with the fascia layer is made. -
FIG. 4I shows bothstrips 24 pushed down intorespective gaps 19 in thewound 15 betweenstaples 17. - At this point, the surgeon needs only to secure the first portion (dressing) 22 down onto the
skin 14 of the patient using the adhesive border.FIGS. 4J-4K show the surgeon applying thefirst portion 22 onto theskin 14 and then removes therelease liner 36 from thefirst portion 22.FIG. 4M depicts theWHD 20/20A releasably secured in place in and over thewound 15. By way of example only, atransparent adhesive 37 overlays the top surface of the dressing 22 (and to which therelease liner 36 was originally attached) that releasably secures the dressing 22 to theskin 14. -
FIG. 5 depicts a third embodiment of the WHD 20B wherein the at least onestrip 24 is replaced by a continuous absorbent member 24B that is formed into a large loop. The loop 24B comprises ends that correspond to ends of thefirst portion 22. -
FIG. 6 depicts a fourth embodiment of theWHD 20C wherein thefirst portion 22 is formed of athin packing material 22A. -
FIG. 7 depicts a fifth embodiment of the WHD 20D which is a combination of the third and fourth embodiments. In particular, thefirst portion 22A is formed of athin packing material 22A and the at least onestrip 24 comprises the large loop 24B. As with the third embodiment 20B, the WHD 20D comprises theloop 24 having ends that correspond to the ends of thefirst portion 22. - Another key improvement to the
WHD 20/20A is the ability to extend the length of the at least onestrip 24A. This can be advantageous for a number of reasons. Allowing the surgeon to adjust the length of the at least onestrip 24 permits the surgeon to customize the absorbing capability of thepresent invention 20 based on the patient's physiology. If, by way of example, the patient has a large girth, it may be necessary to extend the length of the at least onestrip 24, deeper into thesubcutaneous layer 16. - To that end,
FIG. 8 depicts asixth embodiment 20E whereinrespective cartridges 38 of strip material permit thestrips 24 to be extended tonew lengths 24′, shown in phantom. Alternatively,FIG. 9 shows the use of “slack loops” 40 in aseventh embodiment 20F that project from the upper side of thefirst portion 22. Thus, when it becomes necessary to extend the lengths of thestrips 24, the surgeon can push downward on eachstrip 24 to extend the length of each strip to that shown by 24″ by a correspondingdecrease 40′ in theslack loops 40. It should be understood that the term “slack loops” in their broadest sense may include rolled, or folded or tucked fluid absorbent material strips that are located inside or outside thefirst portion 22;FIG. 9A shows an exemplary embodiment 20F1 where the “slack loops” are provided within thefirst portion 22 itself. The arrow indicates movement as thestrip 24 is lengthened and theslack loops 40 are shortened. -
FIG. 10 depicts aneighth embodiment 20G that uses “slip knots” 42 in eachstrip 24 that allow eachstrip 24 to be lengthened by applying a downward force on eachstrip 24; excess material formed in the slip know 42 permits therespective strip 24 to be lengthened 42′. -
FIG. 11 depicts aninth embodiment 20H wherein thesecond portion 24C comprises afoldable portion 44 that can be expanded outward within thesubcutaneous layer 16 once thesecond portion 24C is passed through agap 19 in thewound 15. In particular, once thesecond portion 24 is pushed downward in thegap 19, the surgeon can then expand thefoldable portion 44 along the length of thewound 15 within thesubcutaneous layer 16. - A further variation 20J of the
present invention 20 is the use of freeabsorbent members 24 being placed into the wound in between the staples orsutures 17, wherein the upper ends 24C of the absorbent members are free, as shown most clearly inFIG. 13 . In particular, the surgeon or other healthcare technician can insert each of these freeabsorbent members 24 in between the sutures orstaples 17 in thesubcutaneous layer tissue 16 above themuscle 18, as described previously. As also mentioned previously, these freeabsorbent members 24 may remain in the wound for approximately 1-3 days at which time they are then removed by the surgeon or other healthcare technician. As also mentioned earlier, fluids that form in the wound are absorbed by thestrips 24 and are drawn upward, out of the skin layers 14/16. By removing fluid from these skin layers immediately, the chances for infection are greatly reduced. Furthermore, thefistulae 34 are also formed as described earlier with regard toFIG. 2 . Aseparate dressing 22 may also be applied to the upper ends 24C during the time the freeabsorbent members 24 inserted into the wound, although this is not required. - It should be understood that it is within the broadest scope of the present invention to include the use of all of the embodiments of the WHD in open wounds also. By way of example only, as shown
FIG. 14 , theWHD 20 is placed inside an open wound, i.e., where no sutures or staples are used to close the wound. Thus, the surgeon places thestrips 24 down into the open wound with the dressing 22 being placed at the skin level. Also by way of example only, the variation 20J discussed previously can be placed also into the open wound and then aseparate dressing 22 may be placed in contact with the upper ends 24C of the freeabsorbent members 24. -
FIGS. 15 and 15A provide further embodiments of the WHD to accommodate surrounding items or obstructions at the skin surface that would prevent the dressing 22 from making good contact with the skin surface. In particular,FIG. 15 depicts a top view of thisadditional WHD embodiment 20K whosefirst portion 22 comprises a dressing edge removed, forming acutaway 46. For example, a where a patient has a stoma having a tube or other lumen that is coupled thereto and the wound or incision is closely adjacent that stoma, theWHD embodiment 20K can be positioned as described previously and the dressing 20 can be positioned such that thecutaway 46 is positioned closely adjacent the stoma/tube, thereby allowing the edges of the dressing 22 of theWHD 20K to make good contact with the skin surface and not be interfered with by the stoma/tube. It should be further understood that the shape of the cutaway 46 is by way of example only and it is not limited to a semi-circular contour but may comprise any shape and size. In addition, the relative position of the cutaway 46 can be located along any edge of the dressing 22. -
FIG. 15A shows another embodiment 20L of the WHD wherein an interior portion forming an opening 48 of the dressing 22 is removed. Thus, where the incision or wound is located at a position closely adjacent some obstruction (e.g., a stoma, a tube, a medical device or sensor, etc.) that would prevent the dressing 22 from making sufficient contact with the skin surface, the obstruction (not shown) can be passed through the opening 48 to permit the dressing 22 to be positioned flush against the skin surface. Again, the opening 48 is shown by way of example only; other shapes and other locations on the dressing 22 may comprise the opening 48. - It should be noted that although not required, an anti-microbial composition may be applied to either the
first portion 22 and/or thesecond portion 24. - Thus, the present invention relates to an apparatus/method of wound infection prevention and healing acceleration and life. The
WHD 20 provides the effective post-surgical clean contaminated, contaminated, clean and infected incision when the rate of infection potential is considered significant. The apparatus/method may also be used in a variety of medical surgeries interventions and procedures. Thepresent invention 20 can also be used in veterinary medicine. - The apparatus & method for wound infection device (WHD) 20 is useful for preventing SSI infection for the following surgeries including but is not limited to: general surgery procedures, colorectal, OBGYN procedures, urology, vascular surgeries, and neurosurgery procedures. The incisions or wounds closed following their respective surgeries are susceptible to high infection rates and slow patient recovery periods which also impact the physician, staff, hospital, insurer, etc. Moreover, SSI costs hospitals billions of dollars every year in the U.S. and insurance companies do not reimburse hospitals for maladies caused by infection, and corresponding complications, due to surgical site infection.
- It should be further understood that the term WHD includes any all of kinds of kits that comprise the WHD and any associated components (e.g., a plurality of WHDs; tools that may be used by the surgeon to insert the
second portion 24 into wound site (e.g., pliers, tweezers, dissectors, etc.) that are provided with theWHD 20 itself. - Thus, the apparatus and method for wound infection device (WHD) 20 accelerates the healing process by reducing the healing time by an average of 2 days per patient, which among other things, reduces hospital stay periods.
- While the invention has been described in detail and with reference to specific examples thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.
Claims (10)
1. A method for wound healing that greatly reduces the chances for infection of an incision or wound of a patient, said method comprising:
inserting one end of at least one fluid absorbing material inside the incision or wound;
positioning a second end of said at least one fluid absorbing material to be in fluid communication with another fluid absorbent material that is positioned external of the patient and over top of the incision or wound; and
maintaining said at least one fluid absorbing material and said another fluid absorbent material within and top of the incision or wound respectively, for approximately 1-3 days for conveying fluid out of the incision or wound and into said another fluid absorbent material.
2. The method of claim 1 wherein said second portion comprises at least one strip that is physically coupled to said first portion at said second end.
3. The method of claim 2 wherein said at least one strip comprises a loop.
4. The method of claim 2 wherein the incision or wound is a closed wound or incision via sutures or staples and wherein said at least one strip comprises a plurality of strips, and wherein said step of inserting one end of at least one fluid absorbing material inside a wound comprises each of said strips being inserted inside the wound via respective gaps between sutures or staples of the wound.
5. The method of claim 4 further comprising the step of extending each one of said plurality of strips.
6. The method of claim 1 wherein said step of positioning said another fluid absorbent material external of the patient includes using an adhesive to releasably secure said another fluid absorbent material over the wound.
7. The method of claim 1 further comprising the steps of:
removing said one end of at least one fluid absorbing material inside a wound and removing said another fluid absorbent material from over the wound; and
forming type of fistulae in subcutaneous tissue of the wound and up to the exterior skin level, said type of fistulae causing fluid to continue to drain upward from the wound.
8. A method for wound healing that greatly reduces the chances for infection of an incision or wound of a patient, said method comprising:
forming at least one strand of a fluid absorbing material;
inserting a first end of said at least one strand inside the wound or incision;
positioning a second free end of said at least one strand to be positioned external of the patient; and
maintaining said first end of said at least one strand within the wound for approximately 1-3 days for conveying fluid out of the wound and into said strand.
9. The method of claim 8 further comprising the step of applying a separate fluid absorbing material against said second free end of said at least one strand to convey said fluid absorbed into said at least one strand into said separate fluid absorbing material.
10. The method of claim 8 wherein said incision or wound is a closed wound or incision and wherein said step of inserting a first end of said at least one strand comprises inserting a first end of said at least one strand inside the wound or incision in between sutures or staples of the closed wound or incision.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/728,861 US20230083446A1 (en) | 2013-03-07 | 2022-04-25 | Method for Wound Infection Prevention |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361774272P | 2013-03-07 | 2013-03-07 | |
US201361914720P | 2013-12-11 | 2013-12-11 | |
US14/193,584 US10085892B2 (en) | 2013-03-07 | 2014-02-28 | Apparatus and method for wound infection prevention |
US16/148,876 US11311420B1 (en) | 2013-03-07 | 2018-10-01 | Apparatus for wound infection prevention |
US17/728,861 US20230083446A1 (en) | 2013-03-07 | 2022-04-25 | Method for Wound Infection Prevention |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/148,876 Continuation US11311420B1 (en) | 2013-03-07 | 2018-10-01 | Apparatus for wound infection prevention |
Publications (1)
Publication Number | Publication Date |
---|---|
US20230083446A1 true US20230083446A1 (en) | 2023-03-16 |
Family
ID=51488687
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/193,584 Active US10085892B2 (en) | 2013-03-07 | 2014-02-28 | Apparatus and method for wound infection prevention |
US15/044,399 Abandoned US20160175158A1 (en) | 2013-03-07 | 2016-02-16 | Method for Wound Infection Prevention |
US15/044,460 Abandoned US20160184139A1 (en) | 2013-03-07 | 2016-02-16 | Method for Wound Infection Prevention |
US15/044,413 Abandoned US20160184138A1 (en) | 2013-03-07 | 2016-02-16 | Apparatus for Wound Infection Prevention |
US16/148,876 Active 2035-09-03 US11311420B1 (en) | 2013-03-07 | 2018-10-01 | Apparatus for wound infection prevention |
US17/728,861 Pending US20230083446A1 (en) | 2013-03-07 | 2022-04-25 | Method for Wound Infection Prevention |
Family Applications Before (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/193,584 Active US10085892B2 (en) | 2013-03-07 | 2014-02-28 | Apparatus and method for wound infection prevention |
US15/044,399 Abandoned US20160175158A1 (en) | 2013-03-07 | 2016-02-16 | Method for Wound Infection Prevention |
US15/044,460 Abandoned US20160184139A1 (en) | 2013-03-07 | 2016-02-16 | Method for Wound Infection Prevention |
US15/044,413 Abandoned US20160184138A1 (en) | 2013-03-07 | 2016-02-16 | Apparatus for Wound Infection Prevention |
US16/148,876 Active 2035-09-03 US11311420B1 (en) | 2013-03-07 | 2018-10-01 | Apparatus for wound infection prevention |
Country Status (2)
Country | Link |
---|---|
US (6) | US10085892B2 (en) |
WO (1) | WO2014137824A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10085892B2 (en) * | 2013-03-07 | 2018-10-02 | Life Sciences Llc | Apparatus and method for wound infection prevention |
DE202019105913U1 (en) * | 2018-09-04 | 2019-11-20 | Lohmann & Rauscher Gmbh | Wound cleaning device |
WO2022170163A1 (en) * | 2021-02-07 | 2022-08-11 | Life Sciences Llc | Apparatus and method for wound care device |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020082540A1 (en) * | 1998-06-18 | 2002-06-27 | 3M Innovative Properties Company | Drug delivery dressing having fluid control film |
US20040039415A1 (en) * | 2002-08-21 | 2004-02-26 | Kci Licensing, Inc. | Medical closure screen device and method |
US20040054338A1 (en) * | 2002-09-13 | 2004-03-18 | Farhad Bybordi | Closed wound drainage system |
US20120253302A1 (en) * | 2011-04-04 | 2012-10-04 | Tyco Healthcare Group Lp | Negative Pressure Wound Therapy Dressing |
US10085892B2 (en) * | 2013-03-07 | 2018-10-02 | Life Sciences Llc | Apparatus and method for wound infection prevention |
Family Cites Families (90)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3682180A (en) * | 1970-06-08 | 1972-08-08 | Coilform Co Inc | Drain clip for surgical drain |
US3753439A (en) * | 1971-08-24 | 1973-08-21 | Elias & Brugarolas | General purpose surgical drain |
US4250882A (en) * | 1979-01-26 | 1981-02-17 | Medical Dynamics, Inc. | Wound drainage device |
US4553966A (en) * | 1983-09-19 | 1985-11-19 | Americal Corporation | Device for draining body fluids and irrigating solutions |
FR2566266B1 (en) * | 1984-06-25 | 1986-09-19 | Beghin Say Sa | ADHESIVE DRESSING ALLOWING EASY APPLICATION ON THE SKIN |
US4960467A (en) * | 1985-02-11 | 1990-10-02 | The United States Of America As Represented By The Secretary Of The Army | Dermal substance collection device |
US5153040A (en) * | 1985-03-11 | 1992-10-06 | Minnesota Mining And Manufacturing Co. | Wound dressing |
FI77569C (en) * | 1987-07-13 | 1989-04-10 | Huhtamaeki Oy | ANORDINATION FOR THE PURPOSE OF THE OPERATIONS AND THE OPERATIONS OF ELLER EN VAEVNAD. |
US5078709A (en) * | 1988-04-29 | 1992-01-07 | Evaporating Apparel Industries | Evaporating attachment means suitable for containing and draining fluids emanating from a subject |
US5266371A (en) * | 1988-08-11 | 1993-11-30 | Nitto Denko Corporation | Adhesive dressing sheet |
US4917928A (en) * | 1988-12-02 | 1990-04-17 | Minnesota Mining And Manufacturing Company | Folded adhesive film dressing |
US5053021A (en) * | 1989-05-05 | 1991-10-01 | Feibus Miriam H | Surgical drain |
US5180375A (en) * | 1991-05-02 | 1993-01-19 | Feibus Miriam H | Woven surgical drain and woven surgical sponge |
US5358492A (en) * | 1991-05-02 | 1994-10-25 | Feibus Miriam H | Woven surgical drain and method of making |
US5531999A (en) * | 1991-12-19 | 1996-07-02 | Ndm, Inc. | Rope-shaped wound dressing |
US6767510B1 (en) * | 1992-05-21 | 2004-07-27 | Biosite, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
NZ250214A (en) | 1992-12-23 | 1995-10-26 | Ndm Acquisition Corp | Deep wound dressing and syringe therefor |
GB9411429D0 (en) | 1994-06-08 | 1994-07-27 | Seton Healthcare Group Plc | Wound dressings |
US5840052A (en) | 1995-01-27 | 1998-11-24 | Bertek, Inc. | Adhesive dressing applicator |
US5860259A (en) * | 1995-05-15 | 1999-01-19 | Laska; Walter A. | Masonry insulated board with integral drainage |
US5809826A (en) * | 1996-07-29 | 1998-09-22 | Baker, Jr.; Hugh M. | Inferential condensation sensor |
US6254584B1 (en) * | 1997-01-03 | 2001-07-03 | The Procter & Gamble Company | Thin comfortable interlabial absorbent structure |
US5771967A (en) * | 1996-09-12 | 1998-06-30 | The United States Of America As Represented By The Secretary Of The Navy | Wick-interrupt temperature controlling heat pipe |
IL130575A (en) * | 1996-12-26 | 2004-06-20 | Maurice Amsellem | Self-priming siphon, in particular for irrigation |
US6432096B1 (en) * | 1997-06-16 | 2002-08-13 | The Procter & Gamble Company | Absorbent interlabial device having an integrally formed tab |
US5898964A (en) * | 1998-06-05 | 1999-05-04 | Stanley; Faith Craft | Bumper pad for bed rail |
US7709694B2 (en) | 1998-12-08 | 2010-05-04 | Quick-Med Technologies, Inc. | Materials with covalently-bonded, nonleachable, polymeric antimicrobial surfaces |
US20050033251A1 (en) | 1998-12-08 | 2005-02-10 | Quick-Med Technologies, Inc. | Controlled release of biologically active substances from select substrates |
US6884427B1 (en) | 1999-02-08 | 2005-04-26 | Aderans Research Institute, Inc. | Filamentary means for introducing agents into tissue of a living host |
US6555389B1 (en) * | 1999-05-11 | 2003-04-29 | Aclara Biosciences, Inc. | Sample evaporative control |
IT247481Y1 (en) * | 1999-07-13 | 2002-08-22 | Med Europ S R L | DROP DRAINAGE CORD. |
US6425924B1 (en) * | 2000-03-31 | 2002-07-30 | Ethicon, Inc. | Hernia repair prosthesis |
ES2295182T3 (en) | 2000-07-18 | 2008-04-16 | Coloplast A/S | ONE APOSITO. |
US20030191442A1 (en) * | 2000-08-11 | 2003-10-09 | The Procter & Gamble Company | Topsheet for contacting hydrous body tissues and absorbent device with such a topsheet |
US7888275B2 (en) * | 2005-01-21 | 2011-02-15 | Filtrona Porous Technologies Corp. | Porous composite materials comprising a plurality of bonded fiber component structures |
US7645269B2 (en) * | 2001-04-30 | 2010-01-12 | Kci Licensing, Inc. | Gradient wound treatment system and method |
US6712859B2 (en) * | 2001-06-28 | 2004-03-30 | Ethicon, Inc. | Hernia repair prosthesis and methods for making same |
US7658749B2 (en) * | 2001-09-05 | 2010-02-09 | Wittmann Dietmar H | Method for creating a temporary hypobaric wound space in an intentionally left open surgical wound to diagnose substrate losses and prevent exogenous contamination with microorganisms |
US20030093114A1 (en) | 2001-11-13 | 2003-05-15 | Melvin Levinson | Method for effecting hemostasis |
GB2382989B (en) * | 2001-12-14 | 2005-03-16 | Johnson & Johnson Medical Ltd | Polyurethane foam cavity wound dressings |
GB2390157B (en) * | 2002-06-25 | 2005-09-28 | Johnson & Johnson Medical Ltd | Wound fluid collecting and indicating device |
US7101381B2 (en) * | 2002-08-02 | 2006-09-05 | C.R. Bard, Inc. | Implantable prosthesis |
US7896856B2 (en) * | 2002-08-21 | 2011-03-01 | Robert Petrosenko | Wound packing for preventing wound closure |
US20110240064A1 (en) | 2002-09-09 | 2011-10-06 | Reactive Surfaces, Ltd. | Polymeric Coatings Incorporating Bioactive Enzymes for Cleaning a Surface |
US20100210745A1 (en) | 2002-09-09 | 2010-08-19 | Reactive Surfaces, Ltd. | Molecular Healing of Polymeric Materials, Coatings, Plastics, Elastomers, Composites, Laminates, Adhesives, and Sealants by Active Enzymes |
US7244264B2 (en) * | 2002-12-03 | 2007-07-17 | Roche Diagnostics Operations, Inc. | Dual blade lancing test strip |
US10363344B2 (en) | 2002-12-31 | 2019-07-30 | Kci Licensing, Inc. | Externally-applied patient interface system and method with a controlled region for implanted or buried bio-reactor |
US6951553B2 (en) | 2002-12-31 | 2005-10-04 | Kci Licensing, Inc | Tissue closure treatment system and method with externally-applied patient interface |
US7976519B2 (en) | 2002-12-31 | 2011-07-12 | Kci Licensing, Inc. | Externally-applied patient interface system and method |
GB0308311D0 (en) | 2003-04-10 | 2003-05-14 | Bristol Myers Squibb Co | Wound dressing |
BRPI0411877A (en) * | 2003-06-27 | 2006-08-08 | Procter & Gamble | pseudo distillation method to purify a solvent for dry cleaning |
US7022890B2 (en) * | 2003-09-22 | 2006-04-04 | Ferris Pharmaceuticals | Wound dressing suitable for insertion in nasal passages |
US7182758B2 (en) * | 2003-11-17 | 2007-02-27 | Mccraw John B | Apparatus and method for drainage |
WO2007024972A2 (en) | 2005-08-22 | 2007-03-01 | Quick-Med Technologies, Inc. | Non-leaching absorbent wound dressing |
US20070224087A1 (en) * | 2004-07-08 | 2007-09-27 | Zhong Ding | Airborne material collection and detection method and apparatus |
CA2494023A1 (en) * | 2005-01-24 | 2006-07-24 | R.E.D. International Textiles Inc. | Sleeping bag kit |
DE102005007016A1 (en) | 2005-02-15 | 2006-08-24 | Fleischmann, Wilhelm, Dr.med. | Device for the treatment of wounds |
US20060241689A1 (en) | 2005-04-20 | 2006-10-26 | Leiboff Arnold R | Viscera retainers, surgical drains and methods for using same |
US8795730B2 (en) | 2006-01-31 | 2014-08-05 | David John Vachon | Compositions and methods for promoting the healing of tissue of multicellular organisms |
US7615036B2 (en) * | 2006-05-11 | 2009-11-10 | Kalypto Medical, Inc. | Device and method for wound therapy |
US8030534B2 (en) * | 2006-11-28 | 2011-10-04 | Boehringer Technologies, L.P. | Tunnel dressing for use with negative pressure wound therapy system |
US8771243B2 (en) * | 2007-02-01 | 2014-07-08 | University Of Cincinnati | Wound treatment system |
EP2023123B1 (en) * | 2007-07-26 | 2017-06-21 | Shimadzu Corporation | Optical Measurement Apparatus |
US8623034B2 (en) * | 2007-10-19 | 2014-01-07 | Ethicon, Gmbh | Soft tissue repair implant |
WO2009134414A2 (en) | 2008-04-30 | 2009-11-05 | The Board Of Trustees Of The Leland Stanford Junior University | Devices for the treatment of wounds and methods and kits thereof |
MX2010013323A (en) | 2008-06-04 | 2010-12-21 | Kci Licensing Inc | Reduced-pressure, liquid-collection canister with multi-orientation filter. |
CN102119079B (en) | 2008-06-12 | 2014-09-10 | 3M创新有限公司 | Biocompatible hydrophilic compositions |
US20090313762A1 (en) * | 2008-06-24 | 2009-12-24 | Jaclyn Marie Boutwell | Bumper pads for the prevention of chewing crib rails by small children |
ES2658263T3 (en) * | 2008-08-08 | 2018-03-09 | Smith & Nephew, Inc. | Continuous fiber wound dressing |
US20100106122A1 (en) * | 2008-10-27 | 2010-04-29 | Sessions Pharmaceuticals Inc. | Fluid extracting wound dressing |
AU2009335119B9 (en) * | 2008-12-31 | 2015-08-20 | Solventum Intellectual Properties Company | System for providing fluid flow to nerve tissues |
US8361043B2 (en) | 2009-01-07 | 2013-01-29 | Spiracur Inc. | Reduced pressure therapy of the sacral region |
JP5731475B2 (en) | 2009-03-27 | 2015-06-10 | スリーエム イノベイティブ プロパティズ カンパニー | Hydrophilic polypropylene melt additive |
US8663132B2 (en) * | 2009-04-14 | 2014-03-04 | Kci Licensing, Inc. | Reduced-pressure treatment systems and methods employing a variable cover |
US20120130327A1 (en) * | 2009-05-20 | 2012-05-24 | Marquez Canada Juan | Perfecting of the improved vacuum dressing and the use thereof in vacuum-assisted therapy |
US20100318047A1 (en) * | 2009-06-16 | 2010-12-16 | Ducker Paul M | Absorbent, nonwoven material exhibiting z-direction density gradient |
US20100324516A1 (en) * | 2009-06-18 | 2010-12-23 | Tyco Healthcare Group Lp | Apparatus for Vacuum Bridging and/or Exudate Collection |
US20110015619A1 (en) * | 2009-07-16 | 2011-01-20 | Pal Svedman | Wound dressings for negative pressure therapy in deep wounds and method of using |
WO2011031789A1 (en) * | 2009-09-08 | 2011-03-17 | Atrium Medical Corporation | Hernia patch |
US20110208145A1 (en) * | 2010-02-22 | 2011-08-25 | Le Zhang | Fluid Management System |
US20160346444A1 (en) | 2010-09-24 | 2016-12-01 | Kci Licensing, Inc. | Cellular control and tissue regeneration systems and methods |
US9730535B2 (en) * | 2011-01-21 | 2017-08-15 | Brent Thomas Martin | Layered and secureable spare flaps for rest supports |
US9456930B2 (en) | 2011-07-12 | 2016-10-04 | Kci Licensing, Inc. | Topical vacuum-press surgical incisional dressings, surgical adjuncts, hybrids and composites |
CN103732268B (en) | 2011-08-03 | 2017-02-15 | 凯希特许有限公司 | Reduced-pressure wound dressings |
US9569566B2 (en) * | 2011-12-12 | 2017-02-14 | Zam Research Llc | Simulation and control system and method using contact, pressure waves and factor controls for cell regeneration, tissue closure and related applications |
MX351280B (en) | 2012-01-18 | 2017-10-06 | Worldwide Innovative Healthcare Inc | Modifiable occlusive skin dressing. |
US9278034B2 (en) * | 2012-01-31 | 2016-03-08 | Butterfly Health, Inc. | Devices and methods for treating accidental bowel leakage |
TWM434675U (en) * | 2012-02-20 | 2012-08-01 | Shinetex Entpr Co Ltd | Irreversibly permeating clothing structure |
US10158928B2 (en) * | 2012-04-12 | 2018-12-18 | Elwha Llc | Appurtenances for reporting information regarding wound dressings |
EP3372208B1 (en) | 2012-11-12 | 2022-07-20 | 3M Innovative Properties Company | Externally-applied wound dressings and closures |
-
2014
- 2014-02-28 US US14/193,584 patent/US10085892B2/en active Active
- 2014-02-28 WO PCT/US2014/019519 patent/WO2014137824A1/en active Application Filing
-
2016
- 2016-02-16 US US15/044,399 patent/US20160175158A1/en not_active Abandoned
- 2016-02-16 US US15/044,460 patent/US20160184139A1/en not_active Abandoned
- 2016-02-16 US US15/044,413 patent/US20160184138A1/en not_active Abandoned
-
2018
- 2018-10-01 US US16/148,876 patent/US11311420B1/en active Active
-
2022
- 2022-04-25 US US17/728,861 patent/US20230083446A1/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020082540A1 (en) * | 1998-06-18 | 2002-06-27 | 3M Innovative Properties Company | Drug delivery dressing having fluid control film |
US20040039415A1 (en) * | 2002-08-21 | 2004-02-26 | Kci Licensing, Inc. | Medical closure screen device and method |
US20040054338A1 (en) * | 2002-09-13 | 2004-03-18 | Farhad Bybordi | Closed wound drainage system |
US20120253302A1 (en) * | 2011-04-04 | 2012-10-04 | Tyco Healthcare Group Lp | Negative Pressure Wound Therapy Dressing |
US10085892B2 (en) * | 2013-03-07 | 2018-10-02 | Life Sciences Llc | Apparatus and method for wound infection prevention |
US11311420B1 (en) * | 2013-03-07 | 2022-04-26 | Life Sciences, Llc | Apparatus for wound infection prevention |
Also Published As
Publication number | Publication date |
---|---|
US20160184138A1 (en) | 2016-06-30 |
US20140257218A1 (en) | 2014-09-11 |
US20160184139A1 (en) | 2016-06-30 |
US10085892B2 (en) | 2018-10-02 |
WO2014137824A1 (en) | 2014-09-12 |
US20160175158A1 (en) | 2016-06-23 |
US11311420B1 (en) | 2022-04-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20230083446A1 (en) | Method for Wound Infection Prevention | |
US20180168764A1 (en) | Surgical Drape With Selectively Detachable Barrier | |
JP6336501B2 (en) | Method and apparatus for attaching a negative pressure closure therapy system for a closed incision | |
US8486004B1 (en) | Dressing having integral antimicrobial | |
WO2012161897A2 (en) | Wound dressing system | |
Jester et al. | A one hospital study of the effect of wound dressings and other related factors on skin blistering following total hip and knee arthroplasty | |
US20160262946A1 (en) | Nipple Shield | |
US9186283B2 (en) | Wound dressing | |
US10238374B2 (en) | Tissue protection system and method | |
Hess | Product guide to skin & wound care | |
Knowlton | Nurse's guide to surgical drain removal | |
US20140309497A1 (en) | Tissue protection/retraction system | |
US20060142686A1 (en) | Tissue injury protection medical bridge bandages | |
EP4288008A1 (en) | Apparatus and method for wound care device | |
Moore et al. | Acute surgical wound care 1: an overview of treatment | |
CN208640886U (en) | A kind of debridement protecting towel for wound | |
CN220141949U (en) | Wound protection cover for postoperative | |
CN210330634U (en) | Elastic pulling-closing adhesive tape | |
Yon | The veterinary nurse's role in the management of wound drains | |
CN208741315U (en) | A kind of post-operative hemorrhoids and anal fistula notch fixing belt | |
Owen | Surgical drains | |
Roberts | How to reduce postoperative hospital-acquired infections | |
Singh et al. | A review on caring of surgical wound after surgical procedure | |
Allouni et al. | The Ubiquitous Hospital Polyethelene Pinny; an Ideal Temporary Wound Cover | |
US20150057640A1 (en) | Circular bandage for drain tube |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |